CLSI M33-A:2004
Antiviral Susceptibility Testing: Herpes Simplex Virus by Plaque Reduction Assay; Approved Standard, M33AE
Clinical and Laboratory Standards Institute , 02/01/2004
$84.00
$167.22
This document provides a protocol for the performance of the plaque reduction assay for phenotypic antiviral susceptibility testing of herpes simplex virus.
Product Information
Published:
02/01/2004
Pages:
39
ISBN:
(s):
1562385224
